Previous Close
$1.4
Day Range
$ - $
Previous Day Range
$ - $
Market Cap
$115.0 million USD
Day Vol.
Previous Day Vol.
Currency
USD
Primary Exchange
Nasdaq
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy exp...
Community
- 0 posts discussing
0
Watchers
0
Visitors